机译:Nanomedicine-based癌症免疫疗法由重组肿瘤相关巨噬细胞
Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510632, Peoples R China;
Treatment Outcome; advanced designs; cancer therapyImmunosuppressionNanomedicineTumoursTumor Microenvironmentimmunotherapy cancerreprogrammingMacrophagesAcquired Immunodeficiency SyndromeTamoxifenScientific personnel;
机译:化疗药物引起的免疫原性细胞nanomedicine-based癌症死亡chemo-immunotherapy
机译:撤回注释:用维生素D结合蛋白衍生的巨噬细胞激活因子GcMAF免疫治疗转移性结直肠癌[Cancer Immunology,Immunotherapy,57,(2008)1007-1016,DOI 10.1007 / s00262-007-0431-z]
机译:勘误:淀粉样前体样蛋白2与HLA I类分子的关联(Cancer Immunology,Immunotherapy(2009)58(1419-1431)DOI:10.1007 / s00262-009-0657-z)
机译:Developing Heterostructured Nanoparticles for Cancer Therapeutics =纳米异质结构在癌症治疗中的应用
机译:Investigation of the associations of Genetic polymorphisms in Estrogen metabolism and DNa Repair with the Background Levels of abasic sites and Risk of Developing Breast Cancer